Impact of nonsynonymous single nucleotide polymorphisms on in-vitro metabolism of exemestane by hepatic cytosolic reductases.
about
Exemestane potency is unchanged by common nonsynonymous polymorphisms in CYP19A1: results of a novel anti-aromatase activity assay examining exemestane and its derivatives.In vitro metabolism of exemestane by hepatic cytochrome P450s: impact of nonsynonymous polymorphisms on formation of the active metabolite 17β-dihydroexemestaneGermline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients.Role of the UGT2B17 deletion in exemestane pharmacogenetics.Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily.Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.
P2860
Impact of nonsynonymous single nucleotide polymorphisms on in-vitro metabolism of exemestane by hepatic cytosolic reductases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Impact of nonsynonymous single ...... hepatic cytosolic reductases.
@en
type
label
Impact of nonsynonymous single ...... hepatic cytosolic reductases.
@en
prefLabel
Impact of nonsynonymous single ...... hepatic cytosolic reductases.
@en
P2093
P2860
P1476
Impact of nonsynonymous single ...... hepatic cytosolic reductases.
@en
P2093
Amity Platt
Philip Lazarus
Zuping Xia
P2860
P304
P356
10.1097/FPC.0000000000000226
P577
2016-04-22T00:00:00Z